DRAFT Attachment A - Test Price List.xlsx
XLSX spreadsheet 20 KB Posted
- Solicitation number
- 36C26125Q0190
About this file
This is a draft pricing template spreadsheet for laboratory testing services spanning a base year plus four option years. The template lists 20 specialized medical tests including genetic and neurological tests such as Alzheimer's evaluations, DNA sequencing, and various neurological disorder tests (SCA, CMT, SMA, PKD), with specified quantities for each test ranging from 1-3 units per test. The spreadsheet is structured to capture pricing for each test across all contract years, with spaces to input individual test prices and calculate totals for each period, though no actual pricing is included in this draft version. All years maintain the same test types and quantities, indicating consistent anticipated testing needs throughout the potential contract duration.
The template is part of a broader Department of Veterans Affairs procurement (36C26125Q0190) for reference laboratory testing services at the Sacramento VA Medical Center in Mather, CA, though the pricing information appears in draft form with all pricing fields currently blank and marked as "IGCE: TBD" (Independent Government Cost Estimate: To Be Determined).
View the file
Other files
| File | Type | Posted |
|---|---|---|
| 36C26125Q0190_1.docx | DOCX document | |
| 36C26125Q0190.pdf | ||
| DRAFT Attachment B - PWS.pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
BASE
| Base Year IGCE: TBD | ||||
| TEST CODE | TEST DESCRIPTION | QUANTITY | PRICE | ITEM TOTAL |
| 105 | SCA3 (MJD/ATXN3) Repeat Expansion Test | 3 | ||
| 178 | ADmark® Alzheimer's Evaluation | 2 | ||
| 179 | ADmark® Early Onset Alzheimer's Evaluation | 2 | ||
| 209 | C9ORF72 (FTD) DNA Test | 1 | ||
| 281 | Frontotemporal Dementia (FTD) Evaluation | 1 | ||
| 300 | OMPD Repeat Expansion Test | 2 | ||
| 371 | SCA1 (ATXN1) Repeat Expansion Test | 2 | ||
| 670 | C9orf72 DNA Test | 1 | ||
| 672 | SCA2 (ATXN2) Repeat Expansion Test | 1 | ||
| 1148 | Hemiplegic Migraine Sequencing Evaluation | 2 | ||
| 4001 | CMT Advanced Evaluation - Comprehensive | 1 | ||
| 5026 | SMA Diagnostic Test | 1 | ||
| 5070 | SMA Plus | 1 | ||
| 5103 | CASPR2 Autoantibody Test (Epilepsy) | 1 | ||
| 6106 | Leukoencephalopathy with Vanishing White Matter | 1 | ||
| 6520 | Amyotrophic Lateral Sclerosis Advanced Evaluation | 2 | ||
| 6521 | Atypical Spinal Muscular Atrophy Advanced Sequencing Evaluation | 1 | ||
| 8101 | PKD1 DNA Sequencing and Deletion Evaluation | 1 | ||
| 8101 | Complete PKDx Evaluation | 1 | ||
| 8102 | PKD2 DNA Sequencing and Deletion Evaluation | 1 | ||
| 8104 | PKD2 DNA Sequencing Test | 2 | ||
| TOTALS FOR BASE YEAR | $0.00 |
TOTAL FOR BASE + 4 OPTION YEARS $0.00
OY(1)
| OY(1) Year IGCE: TBD | ||||
| TEST CODE | TEST DESCRIPTION | QUANTITY | PRICE | ITEM TOTAL |
| 105 | SCA3 (MJD/ATXN3) Repeat Expansion Test | 3 | ||
| 178 | ADmark® Alzheimer's Evaluation | 2 | ||
| 179 | ADmark® Early Onset Alzheimer's Evaluation | 2 | ||
| 209 | C9ORF72 (FTD) DNA Test | 1 | ||
| 281 | Frontotemporal Dementia (FTD) Evaluation | 1 | ||
| 300 | OMPD Repeat Expansion Test | 2 | ||
| 371 | SCA1 (ATXN1) Repeat Expansion Test | 2 | ||
| 670 | C9orf72 DNA Test | 1 | ||
| 672 | SCA2 (ATXN2) Repeat Expansion Test | 1 | ||
| 1148 | Hemiplegic Migraine Sequencing Evaluation | 2 | ||
| 4001 | CMT Advanced Evaluation - Comprehensive | 1 | ||
| 5026 | SMA Diagnostic Test | 1 | ||
| 5070 | SMA Plus | 1 | ||
| 5103 | CASPR2 Autoantibody Test (Epilepsy) | 1 | ||
| 6106 | Leukoencephalopathy with Vanishing White Matter | 1 | ||
| 6520 | Amyotrophic Lateral Sclerosis Advanced Evaluation | 2 | ||
| 6521 | Atypical Spinal Muscular Atrophy Advanced Sequencing Evaluation | 1 | ||
| 8101 | PKD1 DNA Sequencing and Deletion Evaluation | 1 | ||
| 8101 | Complete PKDx Evaluation | 1 | ||
| 8102 | PKD2 DNA Sequencing and Deletion Evaluation | 1 | ||
| 8104 | PKD2 DNA Sequencing Test | 2 | ||
| TOTALS FOR OY1 | $0.00 |
OY(2)
| OY(2) Year IGCE: TBD | ||||
| TEST CODE | TEST DESCRIPTION | QUANTITY | PRICE | ITEM TOTAL |
| 105 | SCA3 (MJD/ATXN3) Repeat Expansion Test | 3 | ||
| 178 | ADmark® Alzheimer's Evaluation | 2 | ||
| 179 | ADmark® Early Onset Alzheimer's Evaluation | 2 | ||
| 209 | C9ORF72 (FTD) DNA Test | 1 | ||
| 281 | Frontotemporal Dementia (FTD) Evaluation | 1 | ||
| 300 | OMPD Repeat Expansion Test | 2 | ||
| 371 | SCA1 (ATXN1) Repeat Expansion Test | 2 | ||
| 670 | C9orf72 DNA Test | 1 | ||
| 672 | SCA2 (ATXN2) Repeat Expansion Test | 1 | ||
| 1148 | Hemiplegic Migraine Sequencing Evaluation | 2 | ||
| 4001 | CMT Advanced Evaluation - Comprehensive | 1 | ||
| 5026 | SMA Diagnostic Test | 1 | ||
| 5070 | SMA Plus | 1 | ||
| 5103 | CASPR2 Autoantibody Test (Epilepsy) | 1 | ||
| 6106 | Leukoencephalopathy with Vanishing White Matter | 1 | ||
| 6520 | Amyotrophic Lateral Sclerosis Advanced Evaluation | 2 | ||
| 6521 | Atypical Spinal Muscular Atrophy Advanced Sequencing Evaluation | 1 | ||
| 8101 | PKD1 DNA Sequencing and Deletion Evaluation | 1 | ||
| 8101 | Complete PKDx Evaluation | 1 | ||
| 8102 | PKD2 DNA Sequencing and Deletion Evaluation | 1 | ||
| 8104 | PKD2 DNA Sequencing Test | 2 | ||
| TOTALS FOR OY2 | $0.00 |
OY(3)
| OY(3) Year IGCE: TBD | ||||
| TEST CODE | TEST DESCRIPTION | QUANTITY | PRICE | ITEM TOTAL |
| 105 | SCA3 (MJD/ATXN3) Repeat Expansion Test | 3 | ||
| 178 | ADmark® Alzheimer's Evaluation | 2 | ||
| 179 | ADmark® Early Onset Alzheimer's Evaluation | 2 | ||
| 209 | C9ORF72 (FTD) DNA Test | 1 | ||
| 281 | Frontotemporal Dementia (FTD) Evaluation | 1 | ||
| 300 | OMPD Repeat Expansion Test | 2 | ||
| 371 | SCA1 (ATXN1) Repeat Expansion Test | 2 | ||
| 670 | C9orf72 DNA Test | 1 | ||
| 672 | SCA2 (ATXN2) Repeat Expansion Test | 1 | ||
| 1148 | Hemiplegic Migraine Sequencing Evaluation | 2 | ||
| 4001 | CMT Advanced Evaluation - Comprehensive | 1 | ||
| 5026 | SMA Diagnostic Test | 1 | ||
| 5070 | SMA Plus | 1 | ||
| 5103 | CASPR2 Autoantibody Test (Epilepsy) | 1 | ||
| 6106 | Leukoencephalopathy with Vanishing White Matter | 1 | ||
| 6520 | Amyotrophic Lateral Sclerosis Advanced Evaluation | 2 | ||
| 6521 | Atypical Spinal Muscular Atrophy Advanced Sequencing Evaluation | 1 | ||
| 8101 | PKD1 DNA Sequencing and Deletion Evaluation | 1 | ||
| 8101 | Complete PKDx Evaluation | 1 | ||
| 8102 | PKD2 DNA Sequencing and Deletion Evaluation | 1 | ||
| 8104 | PKD2 DNA Sequencing Test | 2 | ||
| TOTALS FOR OY3 | $0.00 |
OY(4)
| OY(4) Year IGCE: TBD | ||||
| TEST CODE | TEST DESCRIPTION | QUANTITY | PRICE | ITEM TOTAL |
| 105 | SCA3 (MJD/ATXN3) Repeat Expansion Test | 3 | ||
| 178 | ADmark® Alzheimer's Evaluation | 2 | ||
| 179 | ADmark® Early Onset Alzheimer's Evaluation | 2 | ||
| 209 | C9ORF72 (FTD) DNA Test | 1 | ||
| 281 | Frontotemporal Dementia (FTD) Evaluation | 1 | ||
| 300 | OMPD Repeat Expansion Test | 2 | ||
| 371 | SCA1 (ATXN1) Repeat Expansion Test | 2 | ||
| 670 | C9orf72 DNA Test | 1 | ||
| 672 | SCA2 (ATXN2) Repeat Expansion Test | 1 | ||
| 1148 | Hemiplegic Migraine Sequencing Evaluation | 2 | ||
| 4001 | CMT Advanced Evaluation - Comprehensive | 1 | ||
| 5026 | SMA Diagnostic Test | 1 | ||
| 5070 | SMA Plus | 1 | ||
| 5103 | CASPR2 Autoantibody Test (Epilepsy) | 1 | ||
| 6106 | Leukoencephalopathy with Vanishing White Matter | 1 | ||
| 6520 | Amyotrophic Lateral Sclerosis Advanced Evaluation | 2 | ||
| 6521 | Atypical Spinal Muscular Atrophy Advanced Sequencing Evaluation | 1 | ||
| 8101 | PKD1 DNA Sequencing and Deletion Evaluation | 1 | ||
| 8101 | Complete PKDx Evaluation | 1 | ||
| 8102 | PKD2 DNA Sequencing and Deletion Evaluation | 1 | ||
| 8104 | PKD2 DNA Sequencing Test | 2 | ||
| TOTALS FOR OY4 | $0.00 |
File details come from the government source that posted it. Updated .